Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://tiannalpkx373905.shoutmyblog.com/37860011/semaglutide-a-potential-solution-for-diabetes